Scripps Research computational biologist Julia Moore Vogel recently moved back to upstate New York to get help from family members with her severe fatigue caused by long COVID, a condition she has ...
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.
AUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...
Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...
Bilen et al. perform a phase 2 single-arm clinical trial of neoadjuvant cabozantinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma, assess efficacy and find ...
Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients ...
However, as Sheinberg explained, not all “itchy” patients should go on diet trials, and a detailed clinical history could help determine if the patient is a suitable candidate for this test. Among ...
The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...
WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- One in six patients in phase 2 clinical cancer trials receives treatments that are eventually approved, according to a study published online Feb. 25 in ...
Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that U.K. participants can search for possible trials to join.
This course is a practical, interactive workshop for those working in clinical trials who already or wish to actively involve patients or the public in their trials. It offers participants the ...
LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).